By Reenat Sinay ( October 29, 2019, 1:56 PM EDT) -- Prothena investors urged a New York federal court Monday to grant their attorneys at Labaton Sucharow LLP and Levi & Korsinsky LLP $4.7 million in fees and give the final go-ahead to a $15.75 million deal with the biotechnology company, resolving securities fraud claims over a clinical trial....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.